QuidelOrtho Corporation (QDEL)
Total Valuation
QuidelOrtho has a market cap or net worth of $3.23 billion. The enterprise value is $5.65 billion.
Market Cap | 3.23B |
Enterprise Value | 5.65B |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 66.85 million shares outstanding. The number of shares has increased by 16.38% in one year.
Shares Outstanding | 66.85M |
Shares Change (YoY) | +16.38% |
Shares Change (QoQ) | -0.15% |
Owned by Insiders (%) | 7.15% |
Owned by Institutions (%) | 100.63% |
Float | 50.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 17.94 |
PS Ratio | 1.08 |
Forward PS | 1.12 |
PB Ratio | 0.65 |
P/FCF Ratio | 38.32 |
PEG Ratio | 7.19 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.82, with an EV/FCF ratio of 66.99.
EV / Earnings | n/a |
EV / Sales | 1.89 |
EV / EBITDA | 9.82 |
EV / EBIT | 47.71 |
EV / FCF | 66.99 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.52.
Current Ratio | 1.57 |
Quick Ratio | 0.56 |
Debt / Equity | 0.52 |
Debt / EBITDA | 4.49 |
Debt / FCF | 30.66 |
Interest Coverage | 0.80 |
Financial Efficiency
Return on equity (ROE) is -0.20%.
Return on Equity (ROE) | -0.20% |
Return on Assets (ROA) | -0.10% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $422,225 |
Profits Per Employee | -$1,423 |
Employee Count | 7,100 |
Asset Turnover | 0.35 |
Inventory Turnover | 2.73 |
Taxes
Income Tax | -19.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.19% in the last 52 weeks. The beta is 0.11, so QuidelOrtho's price volatility has been lower than the market average.
Beta (1Y) | 0.11 |
52-Week Price Change | -45.19% |
50-Day Moving Average | 55.16 |
200-Day Moving Average | 69.73 |
Relative Strength Index (RSI) | 45.02 |
Average Volume (30 Days) | 1,017,836 |
Short Selling Information
The latest short interest is 2.44 million, so 3.65% of the outstanding shares have been sold short.
Short Interest | 2.44M |
Short Previous Month | 2.37M |
Short % of Shares Out | 3.65% |
Short % of Float | 4.83% |
Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $3.00 billion and -$10.10 million in losses. Loss per share was -$0.15.
Revenue | 3.00B |
Gross Profit | 1.49B |
Operating Income | 139.10M |
Pretax Income | -29.10M |
Net Income | -10.10M |
EBITDA | 575.70M |
EBIT | 118.50M |
Loss Per Share | -$0.15 |
Balance Sheet
The company has $167.30 million in cash and $2.59 billion in debt, giving a net cash position of -$2.42 billion or -$36.20 per share.
Cash & Cash Equivalents | 167.30M |
Total Debt | 2.59B |
Net Cash | -2.42B |
Net Cash Per Share | -$36.20 |
Equity / Book Value | 5.01B |
Book Value Per Share | 74.88 |
Working Capital | 476.70M |
Cash Flow
In the last 12 months, operating cash flow was $280.20 million and capital expenditures -$195.80 million, giving a free cash flow of $84.40 million.
Operating Cash Flow | 280.20M |
Capital Expenditures | -195.80M |
Free Cash Flow | 84.40M |
FCF Per Share | $1.26 |
Margins
Gross margin is 49.85%, with operating and profit margins of 4.64% and -0.34%.
Gross Margin | 49.85% |
Operating Margin | 4.64% |
Pretax Margin | -0.97% |
Profit Margin | -0.34% |
EBITDA Margin | 19.20% |
EBIT Margin | 3.95% |
FCF Margin | 2.82% |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.38% |
Shareholder Yield | -16.38% |
Earnings Yield | -0.31% |
FCF Yield | 2.61% |
Analyst Forecast
The average price target for QuidelOrtho is $61.60, which is 28.49% higher than the current price. The consensus rating is "Hold".
Price Target | $61.60 |
Price Target Difference | 28.49% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 1.03% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 1.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.37 |
Piotroski F-Score | 4 |